Background
Methods
Data collection
Co-morbidity index
Activities of daily living
Statistical analysis
Results
Male (n = 1,852) | Female (n = 3,235) | ||
---|---|---|---|
Age, mean (SD) | 81.8 (6.8) | 83.9 (7.0) | < 0.001 |
Length of stay, median [IQR] | 8 [5; 14] | 8 [5; 13] | n.s. |
Barthel-Index
| |||
80-100 | 296 (17.9%) | 523 (18.2%) | n.s. |
50-79 | 452 (27.3%) | 856 (29.8%) | |
25-49 | 363 (22.0%) | 643 (22.4%) | |
0-24 | 542 (32.8%) | 852 (29.7%) | |
Survival status
| |||
Alive 6th-september 2010 | 563 (30.4%) | 1,322 (40.9%) | < 0.001 |
Discharged and dead before 6th sept. 2010 | 1,115 (60.2%) | 1,670 (51.6%) | |
Dead in hospital | 174 (9.4%) | 243 (7.5%) | |
Charlson Comorbidity Index
| |||
0 | 443 (23.9%) | 1,025 (31.7%) | <0.001 |
1 | 617 (33.3%) | 1,205 (37.3%) | |
2 | 429 (23.2%) | 621 (19.2%) | |
> = 3 | 363 (19.6%) | 384 (11.9%) | |
ICD-diagnosis group
| |||
Infectious diseases (A00 – B99) | 134 (7.2%) | 256 (7.9%) | n.s. |
Any cancer (C00 – C75) | 372 (20.1%) | 485 (15.0%) | < 0.001 |
Haematological disease (D50 – D89) | 322 (17.4%) | 465 (14.4%) | < 0.01 |
Endocrine diseases (E00 – E99) | 636 (34.3%) | 1,317 (40.7%) | < 0.001 |
Psychiatric diseases (F00 – F99) | 488 (26.4%) | 822 (25.4%) | n.s. |
Neurologic diseases (G00 – G99) | 160 (8.6%) | 204 (6.3%) | < 0.01 |
Cardiovascular diseases (I00 – I99) | 1,242 (67.1%) | 2,066 (63.9%) | < 0.05 |
Respiratory diseases (J00 – J99) | 738 (39.8%) | 1,007 (31.1%) | < 0.001 |
Gastrointestinal diseases (K00 – K93) | 291 (15.7%) | 527 (16.3%) | n.s. |
Bone and Connective tissue (M00 – M99) | 271 (14.6%) | 912 (28.2%) | < 0.001 |
Urologic diseases (N00 – N99) | 532 (28.7%) | 682 (21.1%) | < 0.001 |
Number of ICD-diagnosis (mean, SD)
| 4.4 (1.4) | 4.3 (1.4) | n.s. |
Survival 3 month | Survival 12 month | ||||
---|---|---|---|---|---|
OR | 95%-CI | OR | 95%-CI | ||
Barthel Index | Baseline: 80-100 | ||||
50-79 | 0.74 | (0.55 – 0.99)* | 0.80 | (0.65 – 0.97)* | |
25-49 | 0.44 | (0.33 – 0.59)*** | 0.55 | (0.45 – 0.68)*** | |
0-24 | 0.18 | (0.14 – 0.24)*** | 0.29 | (0.24 – 0.35)*** | |
Sex | Male (0), Female (1) | 1.11 | (0.95 – 1.31) n.s. | 1.27 | (1.11– 1.45)*** |
Age | years | 0.96 | (0.95 – 0.97)*** | 0.97 | (0.96 – 0.98)*** |
Charlson Comorbidity Index | Baseline: 0 | ||||
1 | 0.96 | (0.78 – 1.19) n.s. | 0.83 | (0.71 – 0.98)* | |
2 | 0.62 | (0.48 – 0.78)*** | 0.63 | (0.52 – 0.77)*** | |
> = 3 | 0.53 | (0.40 – 0.70)*** | 0.51 | (0.40 – 0.64)*** | |
ICD-10 diagnoses | |||||
Cancer | Diagnoses (C00-D48) | 0.33 | (0.25 – 0.42)*** | 0.38 | (0.29 – 0.49)*** |
Cardiovascular diseases | A-diagnoses (I00-I99) | 0.62 | (0.50 – 0.77)*** | ||
Haematology | Diagnoses (D50-D89) | 0.77 | (0.65 – 0.92)** | ||
Respiratory Diseases | Diagnoses (J00-J99) | 0.59 | (0.50 – 0.69)*** | 0.67 | (0.59 – 0.77)*** |
Infectious Diseases | Diagnoses (A00-B99) | 2.59 | (1.85 – 3.64)*** | 2.24 | (1.78 – 3.36)*** |
Bone and Connective Tissue Diseases | Diagnoses (M00-M79, M86-M99) | 1.54 | (1.26– 1.87)*** | 1.24 | (1.07 – 1.45)** |